100% Same
Salt CompositionEffectivenessStrength
with Substitute Medicine


WHO GMP
Certified

15 Days Easy
Returns

Long Expiry
(>8 Months)

WHO GMP
Certified

15 Days Easy
Returns

Long Expiry
(>8 Months)
Delivery by
In Treatment of Angina (heart-related chest pain)Angina is chest pain or discomfort that happens when there is not enough oxygen-rich blood going to part of your heart. This can occur when the blood vessels of the heart become narrow. By preserving energy metabolism in cells exposed to reduced oxygen supply, Signogard 35mg Tablet MR prevents a decrease in intracellular energy levels, thereby ensuring the proper functioning of heart muscle cells. Signogard 35mg Tablet MR can also help increase your ability to exercise and lead your daily life more easily by reducing the frequency of angina attacks. You should take it regularly and as long as it is prescribed for it to work effectively.Research shows that the frequency of angina attacks reduces significantly after 6 months of treatment with Signogard 35mg Tablet MR.
Side effects of Signogard Tablet MRThe majority of side effects typically do not necessitate medical intervention. and disappear as your body adjusts to the medicine. Doctor consultation is advised if they persist or if you�re worried about them Common side effects of Signogard Dizziness Headache Nausea Vomiting Weakness Rash Abdominal pain Indigestion Itching Diarrhea Hives
How to use Signogard Tablet MRFollow your doctor's guidance regarding the dose and duration of this medication. Ingest it without breaking or crushing. Do not chew, crush or break it. Signogard 35mg Tablet MR is to be taken with food.
How Signogard Tablet MR works Signogard 35mg Tablet MR is an anti-anginal medication. It decreases the oxygen requirement of the heart by shifting its metabolism from fats to glucose. As a result, the heart works more efficiently.
Not Safe: Consuming alcohol with Signogard 35mg Tablet MR may lead to excessive drowsiness.
Information regarding the use of Signogard 35mg Tablet MR during pregnancy is not available. Doctor consultation is advised.
Information regarding the use of Signogard 35mg Tablet MR during breastfeeding is not available. Doctor consultation is advised.
Signogard 35mg Tablet MR may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Signogard 35mg Tablet MR should be used with caution in patients with kidney disease. Dose adjustment of Signogard 35mg Tablet MR may be needed. Doctor consultation is advised.Use of Signogard 35mg Tablet MR is not recommended in patients with severe kidney disease.
There is limited information available on the use of Signogard 35mg Tablet MR in patients with liver disease. Doctor consultation is advised.
If a dose of Signogard 35mg Tablet MR is missed, take it promptly. However, if your next dose is approaching, skip the missed dose and resume your regular schedule. Avoid doubling the dose.
House No-44, Ground Floor, Barthakur Mill Road, Ulubari, Guwahati, Kamrup,Assam, PIN -781007
CiplaMed. Trimetazidine dihydrochloride (29 Apr. 2025)
Trimetazidine (29 Apr. 2025)
Ciapponi A, Pizarro R, Harrison J. WITHDRAWN: Trimetazidine for stable angina. Cochrane Database Syst Rev. 2017 Mar 20;3(3):CD003614. Accessed 29 Apr. 2025]. (online) Available from
MIMS, Philippines: Trimetazidine (29 Apr. 2025)
Trimetazidine dihydrochloride (29 Apr. 2025)
Central Drugs Standard Control Organisation (CDSCO) (19 Mar. 2019)
PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.